#CNBC Insmed CEO on what’s next for company after FDA greenlights lung disease drug
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
Will Lewis, Insmed CEO, joins ‘Fast Money’ to discuss the company’s lung drug being greenlit by the FDA and what it means for for the stock.
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
#MILENIO
コメントを送信